METHOD FOR MONITORING AND/OR PREDICTING THE EFFICACY OF TREATMENT IN A MULTIPLE SCLEROSIS PATIENT

摘要

The present invention provides a new method for determining whether a dimethyl fumarate 10 treatment is effective for a particular Multiple Sclerosis (MS) patient.A pro-tolerogenic shift in the blood leukocyte profile associates with an optimal response to DMF in(relapse remitting MS)RRMS patients. This method and the kit to perform it, allowsfor the identification ofgood responders to DMF treatment once drug administration has been initiated.